Cancer Res. 2012 Apr 1;72(7):1901-2; author reply 1903-4. doi: 10.1158/0008-5472.CAN-11-1540.
Végran and colleagues proposed a model in which the lactate released from tumor cells through MCT4 would be taken up by endothelial cells via the MCT1 transporter and stimulate angiogenesis, using human umbilical vein endothelial cells (HUVECs) as model of tumor endothelial cells. By analyzing a total of 505 cases of human tumor samples immunostained for MCT1, we do not confirm plasma membrane expression of MCT1 in the endothelial cells of tumor-associated vessels.
韦格兰和同事提出了一个模型,即肿瘤细胞通过 MCT4 释放的乳酸盐将被内皮细胞通过 MCT1 转运蛋白摄取,并通过人脐静脉内皮细胞(HUVEC)作为肿瘤内皮细胞的模型刺激血管生成。通过分析总共 505 例免疫组化染色用于 MCT1 的人类肿瘤样本,我们没有确认肿瘤相关血管内皮细胞的 MCT1 质膜表达。